Question 1

Omega 3 fatty acids are best used to help treat:

Accepted Answer

A)  High HDL 
B)  Low LDL 
C)  High triglycerides 
D)  Any high lipid value 
A)  High HDL 
B)  Low LDL 
C)  High triglycerides 
D)  Any high lipid value C

Question 2

When are statins traditionally ordered to be taken?

Accepted Answer

A)  At bedtime 
B)  At noon 
C)  At breakfast 
D)  With the evening meal 
A)  At bedtime 
B)  At noon 
C)  At breakfast 
D)  With the evening meal D

Question 3

The overall goal of treating hyperlipidemia is:

Accepted Answer

A)  Maintain an LDL level of less than 160 mg/dL 
B)  To reduce atherogenesis 
C)  Lowering apo B, one of the apoliproteins 
D)  All of the above 
A)  Maintain an LDL level of less than 160 mg/dL 
B)  To reduce atherogenesis 
C)  Lowering apo B, one of the apoliproteins 
D)  All of the above B

Question 4

Fiber supplements are great options for elderly patients who have the concurrent problem of:

Accepted Answer

A)  End-stage renal failure on fluid restriction 
B)  Recurrent episodes of diarrhea several times a day 
C)  Long-term issues of constipation 
D)  Needing to take multiple medications around the clock every 2 hours 
A)  End-stage renal failure on fluid restriction 
B)  Recurrent episodes of diarrhea several times a day 
C)  Long-term issues of constipation 
D)  Needing to take multiple medications around the clock every 2 hours

Question 5

Sharlene is a 65-year-old patient who has been on a lipid-lowering diet and using plant sterol margarine daily for the past 3 months. Her LDL is 135 mg/dL. An appropriate treatment for her would be:

Accepted Answer

A)  A statin 
B)  Niacin 
C)  A fibric acid derivative 
D)  Determined by her risk factors 
A)  A statin 
B)  Niacin 
C)  A fibric acid derivative 
D)  Determined by her risk factors

Question 6

First-line therapy for hyperlipidemia is:

Accepted Answer

A)  Statins 
B)  Niacin 
C)  Lifestyle changes 
D)  Bile acid-binding resins 
A)  Statins 
B)  Niacin 
C)  Lifestyle changes 
D)  Bile acid-binding resins

Question 7

Which the following persons should not have a statin medication ordered?

Accepted Answer

A)  Someone with 3 first- or second-degree family members with history of muscle issues when started on statins 
B)  Someone with high lipids, but low BMI 
C)  Premenopausal woman with recent history of hysterectomy 
D)  Prediabetic male with known metabolic syndrome 
A)  Someone with 3 first- or second-degree family members with history of muscle issues when started on statins 
B)  Someone with high lipids, but low BMI 
C)  Premenopausal woman with recent history of hysterectomy 
D)  Prediabetic male with known metabolic syndrome

Question 8

James is a 45-year-old patient with an LDL level of 120 and normal triglycerides. Appropriate first-line therapy for James may include diet counseling, increased physical activity, and:

Accepted Answer

A)  A statin 
B)  Niacin 
C)  Sterols 
D)  A fibric acid derivative 
A)  A statin 
B)  Niacin 
C)  Sterols 
D)  A fibric acid derivative

Question 9

When starting a patient on a statin, education would include:

Accepted Answer

A)  If they stop the medication their lipid levels will return to pretreatment levels. 
B)  Medication is a supplement to diet therapy and exercise. 
C)  If they have any muscle aches or pain, they should contact their provider. 
D)  All of the above 
A)  If they stop the medication their lipid levels will return to pretreatment levels. 
B)  Medication is a supplement to diet therapy and exercise. 
C)  If they have any muscle aches or pain, they should contact their provider. 
D)  All of the above

Question 10

When considering which cholesterol-lowering drug to prescribe, which factor determines the type and intensity of treatment?

Accepted Answer

A)  Total LDL 
B)  Fasting HDL 
C)  Coronary artery disease risk level 
D)  Fasting total cholesterol 
A)  Total LDL 
B)  Fasting HDL 
C)  Coronary artery disease risk level 
D)  Fasting total cholesterol

Question 11

Monitoring of a patient who is on a lipid-lowering drug includes:

Accepted Answer

A)  Fasting total cholesterol every 6 months 
B)  Lipid profile with attention to serum LDL 6 to 8 weeks after starting therapy, then again in 6 weeks 
C)  Complete blood count, C-reactive protein, and erythrocyte sedimentation rate after 6 weeks of therapy 
D)  All of the above 
A)  Fasting total cholesterol every 6 months 
B)  Lipid profile with attention to serum LDL 6 to 8 weeks after starting therapy, then again in 6 weeks 
C)  Complete blood count, C-reactive protein, and erythrocyte sedimentation rate after 6 weeks of therapy 
D)  All of the above

Question 12

Jose is a 12-year-old overweight child with a total cholesterol of 180 mg/dL and LDL of 125 mg/dL. Along with diet education and recommending increased physical activity, a treatment plan for Jose would include ____________ with a reevaluation in 6 months.

Accepted Answer

A)  Statins 
B)  Niacin 
C)  Sterols 
D)  Bile acid-binding resins 
A)  Statins 
B)  Niacin 
C)  Sterols 
D)  Bile acid-binding resins

Question 13

What is considered the order of statin strength from lowest effect to highest?

Accepted Answer

A)  Lovastatin, Simvastatin, Rosuvastatin 
B)  Rosuvastatin, Lovastatin, Atorvastatin 
C)  Atorvastatin, Rosuvastatin, Simvastatin 
D)  Simvastatin, Atorvastatin, Lovastatin 
A)  Lovastatin, Simvastatin, Rosuvastatin 
B)  Rosuvastatin, Lovastatin, Atorvastatin 
C)  Atorvastatin, Rosuvastatin, Simvastatin 
D)  Simvastatin, Atorvastatin, Lovastatin

Question 14

Joanne is a 60-year-old patient with an LDL of 132 and a family history of coronary artery disease. She has already tried diet changes (increased fiber and plant sterols) to lower her LDL and after 6 months her LDL is slightly higher. The next step in her treatment would be:

Accepted Answer

A)  A statin 
B)  Niacin 
C)  Sterols 
D)  A fibric acid derivative 
A)  A statin 
B)  Niacin 
C)  Sterols 
D)  A fibric acid derivative

Question 15

Phil is a 54-year-old male with multiple risk factors who has been on a high-dose statin for 3 months to treat his high LDL level. His LDL is 135 mg/dL and his triglycerides are elevated. A reasonable change in therapy would be to:

Accepted Answer

A)  Discontinue the statin and change to a fibric acid derivative. 
B)  Discontinue the statin and change to ezetimibe. 
C)  Continue the statin and add in ezetimibe. 
D)  Refer him to a specialist in managing patients with recalcitrant hyperlipidemia. 
A)  Discontinue the statin and change to a fibric acid derivative. 
B)  Discontinue the statin and change to ezetimibe. 
C)  Continue the statin and add in ezetimibe. 
D)  Refer him to a specialist in managing patients with recalcitrant hyperlipidemia.

Question 16

Before starting therapy with a statin, the following baseline laboratory values should be evaluated:

Accepted Answer

A)  Complete blood count 
B)  Liver function (ALT/AST) and creatine kinase 
C)  C-reactive protein 
D)  All of the above 
A)  Complete blood count 
B)  Liver function (ALT/AST) and creatine kinase 
C)  C-reactive protein 
D)  All of the above

Question 17

Han is a 48-year-old diabetic with hyperlipidemia and high triglycerides. His LDL is 112 mg/dL and he has not tolerated statins. He warrants a trial of a:

Accepted Answer

A)  Sterol 
B)  Niacin 
C)  Fibric acid derivative 
D)  Bile acid-binding resin 
A)  Sterol 
B)  Niacin 
C)  Fibric acid derivative 
D)  Bile acid-binding resin

Question 18

Jamie is a 34-year-old pregnant woman with familial hyperlipidemia and elevated LDL levels. What is the appropriate treatment for a pregnant woman?

Accepted Answer

A)  A statin 
B)  Niacin 
C)  Fibric acid derivative 
D)  Bile acid-binding resins 
A)  A statin 
B)  Niacin 
C)  Fibric acid derivative 
D)  Bile acid-binding resins

Exam 39: Hyperlipidemia

Omega 3 fatty acids are best used to help treat:

When are statins traditionally ordered to be taken?

The overall goal of treating hyperlipidemia is:

Fiber supplements are great options for elderly patients who have the concurrent problem of:

Sharlene is a 65-year-old patient who has been on a lipid-lowering diet and using plant sterol margarine daily for the past 3 months. Her LDL is 135 mg/dL. An appropriate treatment for her would be:

First-line therapy for hyperlipidemia is:

Which the following persons should not have a statin medication ordered?

James is a 45-year-old patient with an LDL level of 120 and normal triglycerides. Appropriate first-line therapy for James may include diet counseling, increased physical activity, and:

When starting a patient on a statin, education would include:

When considering which cholesterol-lowering drug to prescribe, which factor determines the type and intensity of treatment?

Monitoring of a patient who is on a lipid-lowering drug includes:

Jose is a 12-year-old overweight child with a total cholesterol of 180 mg/dL and LDL of 125 mg/dL. Along with diet education and recommending increased physical activity, a treatment plan for Jose would include ____________ with a reevaluation in 6 months.

What is considered the order of statin strength from lowest effect to highest?

Joanne is a 60-year-old patient with an LDL of 132 and a family history of coronary artery disease. She has already tried diet changes (increased fiber and plant sterols) to lower her LDL and after 6 months her LDL is slightly higher. The next step in her treatment would be:

Phil is a 54-year-old male with multiple risk factors who has been on a high-dose statin for 3 months to treat his high LDL level. His LDL is 135 mg/dL and his triglycerides are elevated. A reasonable change in therapy would be to:

Before starting therapy with a statin, the following baseline laboratory values should be evaluated:

Han is a 48-year-old diabetic with hyperlipidemia and high triglycerides. His LDL is 112 mg/dL and he has not tolerated statins. He warrants a trial of a:

Jamie is a 34-year-old pregnant woman with familial hyperlipidemia and elevated LDL levels. What is the appropriate treatment for a pregnant woman?

The Role of the Nurse Practitioner

Review of Basic Principles of Pharmacology

Rational Drug Selection

Legal and Professional Issues in Prescribing

Adverse Drug Reactions

Factors That Foster Positive Outcomes

Cultural and Ethnic Influences in Pharmacotherapeutics

An Introduction to Pharmacogenomics

Nutrition and Nutraceuticals

Herbal Therapy and Nutritional Supplements

Information Technology and Pharmacotherapeutics

Pharmacoeconomics

Over-The-Counter Medications

Drugs Affecting the Autonomic Nervous System

Drugs Affecting the Central Nervous System

Drugs Affecting the Cardiovascular and Renal Systems

Drugs Affecting the Respiratory System

Drugs Affecting the Hematopoietic System

Drugs Affecting the Immune System

Drugs Affecting the Gastrointestinal System

Drugs Affecting the Endocrine System

Drugs Affecting the Reproductive System

Drugs Affecting the Integumentary System

Drugs Used in Treating Infectious Diseases

Drugs Used in Treating Inflammatory Processes

Drugs Used in Treating Eye and Ear Disorders

Anemia

Chronic Stable Angina and Low-Risk Unstable Angina

Anxiety and Depression

Asthma and Chronic Obstructive Pulmonary Disease

Contraception

Dermatologic Conditions

Diabetes Mellitus

Gastroesophageal Reflux and Peptic Ulcer Disease

Headaches

Heart Failure

Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome

Hormone Replacement Therapy and Osteoporosis

Hypertension

Hyperthyroidism and Hypothyroidism

Pneumonia

Smoking Cessation

Sexually Transmitted Infections and Vaginitis

Tuberculosis

Upper Respiratory Infections, Otitis Media, and Otitis Externa

Urinary Tract Infections

Women As Patients

Men As Patients

Children As Patients

Geriatric Patients

Pain Management: Acute and Chronic Pain

Filters